SCHEMBL674630

SCHEMBL674630

COCCOc1nc(N)c(N)cc1C(=O)N[C@H]1CC[C@H](C(F)(F)F)CC1.COCCOc1nc(N)c([N+](=O)[O-])cc1C(=O)N[C@H]1CC[C@H](C(F)(F)F)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MLNR O43193 1/20 0.37
ADRB2 P07550 1/20 0.37
CHRM1 P11229 1/20 0.37
DRD2 P14416 1/20 0.37
ADRA2B P18089 1/20 0.37
ADRA2C P18825 1/20 0.37
CHRM3 P20309 1/20 0.37
SLC6A2 P23975 1/20 0.37
HTR2A P28223 1/20 0.37
SLC6A4 P31645 1/20 0.37
HRH1 P35367 1/20 0.37
DRD3 P35462 1/20 0.37
OPRK1 P41145 1/20 0.37
HTR2B P41595 1/20 0.37
CHRNA4 P43681 1/20 0.37
HTR3A P46098 1/20 0.37
SLC6A3 Q01959 1/20 0.37
KCNH2 Q12809 1/20 0.37
HRH3 Q9Y5N1 1/20 0.37
CD38 P28907 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL674631 1.00 MLNR (0.37) MLNRADRB2CHRM1DRD2ADRA2B
SCHEMBL674632 1.00 MLNR (0.37) MLNRADRB2CHRM1DRD2ADRA2B
SCHEMBL11909205 0.97 ALDH1A1 (0.39) MLNRADRB2CHRM1DRD2ADRA2B
SCHEMBL11909206 0.97 ALDH1A1 (0.39) MLNRADRB2CHRM1DRD2ADRA2B
SCHEMBL11908919 0.91 TYK2 (0.41) DRD2CD38ALDH1A1TYK2POLB
SCHEMBL11908921 0.91 TYK2 (0.41) DRD2CD38ALDH1A1TYK2POLB
SCHEMBL11980765 0.90 CNR2 (0.39) MLNRADRB2CHRM1DRD2ADRA2B
SCHEMBL11907927 0.89 ALDH1A1 (0.39) MLNRADRB2CHRM1DRD2ADRA2B
SCHEMBL673728 0.89 ALDH1A1 (0.39) MLNRADRB2CHRM1DRD2ADRA2B
SCHEMBL11907925 0.89 ALDH1A1 (0.39) MLNRADRB2CHRM1DRD2ADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2606046-A1 2-(ARYLAMINO)-3H-IMIDAZO[4,5-B]PYRIDINE-6-CARBOXAMIDE DERIVATIVES AND THEIR USE AS MPGES-1 INHIBITORS Boehringer Ingelheim International GmbH (DE) 2013-06-26 EP disclosed
WO-2012022792-A1 2-(ARYLAMINO)-3H-IMIDAZO[4,5-B]PYRIDINE-6-CARBOXAMIDE DERIVATIVES AND THEIR USE AS MPGES-1 INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-02-23 WO disclosed